For release: 07.05, 31 December 2024
EMV Capital
plc
(EMVC
or the Company)
Grant of Share
Options
EMV Capital plc (AIM: EMVC), the
deeptech and life sciences VC investment group, announces that it
has granted a total of 345,000 new options (New Options) to subscribe for ordinary
shares in the capital of the Company (Ordinary Shares) to its directors and a
PDMR, as detailed below.
In line with the Company's
remuneration policy, the Remuneration Committee has approved the
award of the following New Options to the Executive Directors and a
PDMR as referred to below in connection with their annual
remuneration. In addition, the Company's Board has approved the
award of the following New Options to its Non-Executive
Directors.
Director
|
New
Options
|
Total options held (including existing
options)
|
Dr Ilian Iliev, CEO
|
120,000
|
685,656
|
Ed Hooper, Executive
Director
|
120,000
|
685,656
|
Dr Charles Spicer, Chair
|
30,000
|
125,238
|
Dr Jonathan Robinson, Senior
Independent Director
|
30,000
|
99,610
|
Nick Salisbury, PDMR
|
45,000
|
45,000
|
The New Options were granted under
the EMV Capital Share Option Scheme, pursuant to which options over
a total of 2,417,732 Ordinary Shares have now been granted
(excluding lapsed options but including exercised options),
representing approximately 8.71 per cent. of the Company's issued
share capital. The maximum potential dilution arising from options
awarded under the EMV Capital Share Option Scheme remains below the
upper limit of 10 per cent. under the rules of the plan.
The New Options have an exercise
price of 50 pence per share, which price is equal to the issue
price for the Company's recent share issuance (announced 5 December
2024) and higher than the average of the closing market quotations
for Ordinary Shares over the five dealing days prior to the date on
which the New Options were granted (the latter being the minimum
price that could have been set).
The New Options will vest as to one
third on the date of grant, as to a further third on the first
anniversary of the date of grant and as to the final third on the
second anniversary of the date of grant. The New Options may not be
exercised earlier than the third anniversary of the date of grant
and lapse 10 years after the date of grant (if not sooner in
accordance with the terms of the EMV Capital Share Option Scheme
rules).
The FCA notification, made in
accordance with the requirements of the EU Market Abuse Regulation,
is appended below.
The person responsible for arranging the release of this
announcement on behalf of the Company is Ed Hooper, Executive
Director and General Counsel of the Company.
THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES
OF ARTICLE 7 OF THE UK VERSION OF REGULATION (EU) NO 596/2014 WHICH
IS PART OF UK LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT
2018, AS AMENDED. UPON THE PUBLICATION OF THIS ANNOUNCEMENT VIA A
REGULATORY INFORMATION SERVICE, THIS INSIDE INFORMATION IS NOW
CONSIDERED TO BE IN THE PUBLIC DOMAIN.
-Ends-
For
more information, please contact:
|
EMV
Capital plc
|
via Rosewood
|
Ilian Iliev, CEO
|
|
|
|
Panmure Liberum (UK) Limited (NOMAD and Broker)
|
+44 (0)20 7886 2500
|
Emma Earl / Will Goode / Freddy
Crossley / Mark Rogers (Corporate Finance)
|
|
Rupert Dearden (Corporate
Broking)
|
|
|
|
Rosewood (Financial
PR)
|
+44 (0)20 7653 8702
|
John West / Llewellyn Angus / Lily Pearce
|
|
About EMV Capital plc (EMVC)
EMV Capital plc, formerly known as
NetScientific plc, is a deep tech and life sciences venture capital
investment group with an international portfolio of high-growth
companies.
With a strategic focus on generating
superior returns for investors from the fast-growing sectors and
technologies that will define our future; EMV Capital invests in,
manages and strengthens early stage IP-rich companies.
EMV Capital holds both direct equity
stakes and carried interest in its portfolio companies, creating an
evergreen structure that supports extensive growth and value
creation. EMV Capital's investment thesis is realised through these
capital sources:
·
capital-efficient investments through Group
balance sheet;
·
fund management of the Evergreen EIS and Martlet
Capital Funds;
·
syndicated investments leveraging its network of
third-party investors.
EMV Capital's approach is
characterised by its proactive management style, aiming to advance
portfolio companies to critical value inflection points by actively
engaging with them. Companies are supported through Board
representation and the use of its Value Creation Services
practice.
Headquartered in London, with a
Cambridge presence and strong international links, EMV Capital is
quoted on the AIM market of the London Stock Exchange.
For more information, visit
www.emvcapital.com
NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS
DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY
ASSOCIATED WITH THEM
1
|
Details of the person discharging managerial responsibilities
/ person closely associated
|
a)
|
Name
|
Dr Ilian Iliev
|
2
|
Reason for the notification
|
a)
|
Position/status
|
Director
|
b)
|
Initial notification
/Amendment
|
Initial Notification
|
3
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
|
a)
|
Name
|
EMV Capital plc
|
b)
|
LEI
|
213800N5WD46G1Y7I458
|
4
|
Details of the transaction(s): section to be repeated for (i)
each type of instrument; (ii) each type of transaction; (iii) each
date; and (iv) each place where transactions have been
conducted
|
a)
|
Description of the financial
instrument, type of instrument
Identification code
|
Options over EMVC 5p Ordinary
Shares
GB00BN4R5Q82
|
b)
|
Nature of the
transaction
|
Grant of options
|
c)
|
Price(s) and volume(s)
|
Price(s)
|
Volume(s)
|
£0.50
|
120,000 options
|
|
d)
|
Aggregated information
- Aggregated volume
- Price
|
N/a
|
e)
|
Date of the transaction
|
30 December 2024
|
f)
|
Place of the transaction
|
UK AIM
|
1
|
Details of the person discharging managerial responsibilities
/ person closely associated
|
a)
|
Name
|
Ed Hooper
|
2
|
Reason for the notification
|
a)
|
Position/status
|
Director
|
b)
|
Initial notification
/Amendment
|
Initial Notification
|
3
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
|
a)
|
Name
|
EMV Capital plc
|
b)
|
LEI
|
213800N5WD46G1Y7I458
|
4
|
Details of the transaction(s): section to be repeated for (i)
each type of instrument; (ii) each type of transaction; (iii) each
date; and (iv) each place where transactions have been
conducted
|
a)
|
Description of the financial
instrument, type of instrument
Identification code
|
Options over EMVC 5p Ordinary
Shares
GB00BN4R5Q82
|
b)
|
Nature of the
transaction
|
Grant of options
|
c)
|
Price(s) and volume(s)
|
Price(s)
|
Volume(s)
|
£0.50
|
120,000 options
|
|
d)
|
Aggregated information
- Aggregated volume
- Price
|
N/a
|
e)
|
Date of the transaction
|
30 December 2024
|
f)
|
Place of the transaction
|
UK AIM
|
1
|
Details of the person discharging managerial responsibilities
/ person closely associated
|
a)
|
Name
|
Dr Charles Spicer
|
2
|
Reason for the notification
|
a)
|
Position/status
|
Director
|
b)
|
Initial notification
/Amendment
|
Initial Notification
|
3
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
|
a)
|
Name
|
EMV Capital plc
|
b)
|
LEI
|
213800N5WD46G1Y7I458
|
4
|
Details of the transaction(s): section to be repeated for (i)
each type of instrument; (ii) each type of transaction; (iii) each
date; and (iv) each place where transactions have been
conducted
|
a)
|
Description of the financial
instrument, type of instrument
Identification code
|
Options over EMVC 5p Ordinary
Shares
GB00BN4R5Q82
|
b)
|
Nature of the
transaction
|
Grant of options
|
c)
|
Price(s) and volume(s)
|
Price(s)
|
Volume(s)
|
£0.50
|
30,000 options
|
|
d)
|
Aggregated information
- Aggregated volume
- Price
|
N/a
|
e)
|
Date of the transaction
|
30 December 2024
|
f)
|
Place of the transaction
|
UK AIM
|
1
|
Details of the person discharging managerial responsibilities
/ person closely associated
|
a)
|
Name
|
Dr Jonathan Robinson
|
2
|
Reason for the notification
|
a)
|
Position/status
|
Director
|
b)
|
Initial notification
/Amendment
|
Initial Notification
|
3
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
|
a)
|
Name
|
EMV Capital plc
|
b)
|
LEI
|
213800N5WD46G1Y7I458
|
4
|
Details of the transaction(s): section to be repeated for (i)
each type of instrument; (ii) each type of transaction; (iii) each
date; and (iv) each place where transactions have been
conducted
|
a)
|
Description of the financial
instrument, type of instrument
Identification code
|
Options over EMVC 5p Ordinary
Shares
GB00BN4R5Q82
|
b)
|
Nature of the
transaction
|
Grant of options
|
c)
|
Price(s) and volume(s)
|
Price(s)
|
Volume(s)
|
£0.50
|
30,000 options
|
|
d)
|
Aggregated information
- Aggregated volume
- Price
|
N/a
|
e)
|
Date of the transaction
|
30 December 2024
|
f)
|
Place of the transaction
|
UK AIM
|
1
|
Details of the person discharging managerial responsibilities
/ person closely associated
|
a)
|
Name
|
Nick Salisbury
|
2
|
Reason for the notification
|
a)
|
Position/status
|
PDMR
|
b)
|
Initial notification
/Amendment
|
Initial Notification
|
3
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
|
a)
|
Name
|
EMV Capital plc
|
b)
|
LEI
|
213800N5WD46G1Y7I458
|
4
|
Details of the transaction(s): section to be repeated for (i)
each type of instrument; (ii) each type of transaction; (iii) each
date; and (iv) each place where transactions have been
conducted
|
a)
|
Description of the financial
instrument, type of instrument
Identification code
|
Options over EMVC 5p Ordinary
Shares
GB00BN4R5Q82
|
b)
|
Nature of the
transaction
|
Grant of options
|
c)
|
Price(s) and volume(s)
|
Price(s)
|
Volume(s)
|
£0.50
|
45,000 options
|
|
d)
|
Aggregated information
- Aggregated volume
- Price
|
N/a
|
e)
|
Date of the transaction
|
30 December 2024
|
f)
|
Place of the transaction
|
UK AIM
|